Effector EgeA Facilitates Infection by Hijacking TANGO1 and SCFD1 from ER-Golgi Exit Sites to Pathogen-occupied Inclusions
Overview
Authors
Affiliations
The obligatory intracellular bacterium causes human granulocytic anaplasmosis, an emerging zoonosis. has limited biosynthetic and metabolic capacities, yet it effectively replicates inside of inclusions/vacuoles of eukaryotic host cells. Here, we describe a unique Type IV secretion system (T4SS) effector, R-olgi xit site protein of (EgeA). In cells infected by , secreted native EgeA, EgeA-GFP, and the C-terminal half of EgeA (EgeA-C)-GFP localized to containing inclusions. In uninfected cells, EgeA-C-GFP localized to cis-Golgi, whereas the N-terminal half of EgeA-GFP localized to the ER. Pull-down assays identified EgeA-GFP binding to a transmembrane protein in the ER, Transport and Golgi organization protein 1 (TANGO1). By yeast two-hybrid analysis, EgeA-C directly bound Sec1 family domain-containing protein 1 (SCFD1), a host protein of the cis-Golgi network that binds TANGO1 at ER-Golgi exit sites (ERES). Both TANGO1 and SCFD1 localized to the inclusion surface. Furthermore, knockdown of EgeA or either host TANGO1 or SCFD1 significantly reduced infection. TANGO1 and SCFD1 prevent ER congestion and stress by facilitating transport of bulky or unfolded proteins at ERES. A bulky cargo collagen and the ER-resident chaperon BiP were transported into inclusions, and several ER stress marker genes were not up-regulated in infected cells. Furthermore, EgeA transfection reduced collagen overexpression-induced BiP upregulation. These results suggest that by binding to the two ERES proteins, EgeA redirects the cargo-adapted ERES to pathogen-occupied inclusions and reduces ERES congestion, which facilitates nutrient acquisition and reduces ER stress for survival and proliferation.
AFAP targets the host nucleolus and inhibits induced apoptosis.
Zhang D, Yu L, Tang H, Niu H Front Microbiol. 2025; 15():1533640.
PMID: 39839117 PMC: 11747512. DOI: 10.3389/fmicb.2024.1533640.
ATF6 enables pathogen infection in ticks by inducing and altering cholesterol dynamics.
Vosbigian K, Wright S, Rosche K, Fisk E, Ramirez-Zepp E, Shelden E bioRxiv. 2025; .
PMID: 39829801 PMC: 11741349. DOI: 10.1101/2025.01.08.632023.